FHA
AMPE

Flagship Harbor Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Flagship Harbor Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-156
Closed -$3K – 645
2022
Q3 		$3K Hold
156
– – ﹤0.01% 587
2022
Q2 		$8K Hold
156
– – ﹤0.01% 591
2022
Q1 		$22K Hold
156
– – ﹤0.01% 615
2021
Q4 		$27K Buy
156
+55
+54% +$20.5K ﹤0.01% 641
2021
Q3 		$51K Hold
101
– – 0.01% 620
2021
Q2 		$51K Buy
101
+2
+2% +$1.07K 0.01% 624
2021
Q1 		$50K Buy
99
+25
+34% +$12.9K 0.01% 616
2020
Q4 		$35K Buy
+74
New +$24.3K ﹤0.01% 553

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Flagship Harbor Advisors's AMPE Position: Q4 2022 in Review

Flagship Harbor Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 156 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in AMPE in Q4 2020 and held it in 8 quarters. The position peaked at $51K in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Flagship Harbor Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Flagship Harbor Advisors sold 156 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $3K.
  • Flagship Harbor Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 8 quarters.
  • Flagship Harbor Advisors's Ampio Pharmaceuticals Inc. position peaked at $51K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Flagship Harbor Advisors's 13F filing for Q4 2022, filed 13 Jan 2023.